OncoSec Medical Insiders

ONCSDelisted Stock  USD 0.06  0  3.63%   
OncoSec Medical employs about 40 people. The company is managed by 7 executives with a total tenure of roughly 94 years, averaging almost 13.0 years of service per executive, having 5.71 employees per reported executive. Breaking down OncoSec Medical's management performance can provide insight into the firm performance.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

OncoSec Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.9284) % which means that it has lost $0.9284 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.1017) %, meaning that it created substantial loss on money invested by shareholders. OncoSec Medical's management efficiency ratios could be used to measure how well OncoSec Medical manages its routine affairs as well as how well it operates its assets and liabilities.

OncoSec Medical Workforce Comparison

OncoSec Medical is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 251. OncoSec Medical retains roughly 40.0 in number of employees claiming about 16% of equities under Health Care industry.

OncoSec Medical Notable Stakeholders

An OncoSec Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as OncoSec Medical often face trade-offs trying to please all of them. OncoSec Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting OncoSec Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert CPAVP ControllerProfile
Kim JaffeAssistant OperationsProfile
Robert ArchCEO PresProfile
Tu MScVP OperationsProfile
CPA CFAExec CFOProfile
Mai MDConsultantProfile
Sandra AungSr OfficerProfile

About OncoSec Medical Management Performance

The success or failure of an entity such as OncoSec Medical often depends on how effective the management is. OncoSec Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of OncoSec management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the OncoSec management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey. Oncosec Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.
Please note, the imprecision that can be found in OncoSec Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of OncoSec Medical. Check OncoSec Medical's Beneish M Score to see the likelihood of OncoSec Medical's management manipulating its earnings.

OncoSec Medical Workforce Analysis

Traditionally, organizations such as OncoSec Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare OncoSec Medical within its industry.

OncoSec Medical Manpower Efficiency

Return on OncoSec Medical Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee854.5K
Net Loss Per Executive4.9M
Working Capital Per Employee215K
Working Capital Per Executive1.2M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Consideration for investing in OncoSec Stock

If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm